SG10201606442QA - Method for treating schizophrenia - Google Patents
Method for treating schizophreniaInfo
- Publication number
- SG10201606442QA SG10201606442QA SG10201606442QA SG10201606442QA SG10201606442QA SG 10201606442Q A SG10201606442Q A SG 10201606442QA SG 10201606442Q A SG10201606442Q A SG 10201606442QA SG 10201606442Q A SG10201606442Q A SG 10201606442QA SG 10201606442Q A SG10201606442Q A SG 10201606442QA
- Authority
- SG
- Singapore
- Prior art keywords
- treating schizophrenia
- schizophrenia
- treating
- Prior art date
Links
- 201000000980 schizophrenia Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/88—Unsaturated compounds containing keto groups containing halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161515418P | 2011-08-05 | 2011-08-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201606442QA true SG10201606442QA (en) | 2016-09-29 |
Family
ID=47627335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201606442QA SG10201606442QA (en) | 2011-08-05 | 2012-08-03 | Method for treating schizophrenia |
Country Status (18)
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103450128B (zh) * | 2013-08-15 | 2015-04-08 | 河南中帅医药科技股份有限公司 | 用于治疗青光眼的前列腺素类似物中间体Corey醛的制备方法 |
US20150057351A1 (en) * | 2013-08-22 | 2015-02-26 | Sucampo Ag | Method for treating neuropathic pain |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5428062A (en) | 1987-01-28 | 1995-06-27 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti ulcers containing same |
US5225439A (en) | 1987-01-28 | 1993-07-06 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti ulcers containing same |
CA1322749C (en) * | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
US5166174A (en) | 1987-01-28 | 1992-11-24 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti-ulcers containing same |
US5591887A (en) | 1987-04-30 | 1997-01-07 | R-Tech Ueno, Ltd. | Prostaglandins of the F series |
US5221763A (en) | 1987-04-30 | 1993-06-22 | R-Tech Ueno, Ltd. | Prostaglandins of the F series |
CA1324129C (en) | 1987-04-30 | 1993-11-09 | Ryuzo Ueno | Prostaglandins of the f series |
ATE108330T1 (de) * | 1987-09-18 | 1994-07-15 | R Tech Ueno Ltd | Hypotensive okulare mittel. |
CA2030345C (en) | 1989-11-22 | 1998-12-08 | Ryuji Ueno | Use of 15-keto-prostaglandin compound for improvement of encephalic function |
CA2039420C (en) | 1990-04-04 | 1996-12-10 | Ryuji Ueno | Treatment of cataract with 15-keto-prostaglandin compounds |
CA2150287C (en) | 1994-06-03 | 2004-08-10 | Ryuji Ueno | Agent for treating hepato-biliary diseases |
DE69714698T2 (de) | 1996-06-10 | 2002-12-05 | Sucampo Ag, Zug | Endothelin-antagonisten |
TWI225398B (en) * | 1999-07-14 | 2004-12-21 | R Tech Ueno Ltd | Composition for treatment of external secretion disorders |
ITRM20010356A1 (it) * | 2001-06-21 | 2002-12-23 | Sigma Tau Ind Farmaceuti | "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina. |
IL157751A0 (en) * | 2003-02-28 | 2004-03-28 | Yissum Res Dev Co | New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them |
US20040224995A1 (en) * | 2003-05-09 | 2004-11-11 | University Of North Texas Health Science Center At Fort Worth | Neuroprotective effects of PPARy agonists against cellular oxidative insults |
EP1841433B1 (en) * | 2005-01-27 | 2011-11-30 | Sucampo AG | Composition for treating central nervous system disorders |
US8143316B2 (en) * | 2005-03-04 | 2012-03-27 | Sucampo Ag | Method for treating peripheral vascular diseases |
US7211703B2 (en) * | 2005-04-27 | 2007-05-01 | Calgon Carbon Corporation | Method of separating E and Z isomers of an alkene alcohol and derivatives thereof |
US20080255203A1 (en) * | 2007-04-12 | 2008-10-16 | Abbott Laboratories | Heterocyclic compounds and their methods of use |
KR101485212B1 (ko) * | 2007-07-19 | 2015-01-22 | 가부시키가이샤 아루떼꾸 우에노 | 11-데옥시-프로스타글란딘 화합물을 포함하는 약학 조성물 및 상기 화합물을 안정화시키는 방법 |
JP6023082B2 (ja) * | 2011-01-24 | 2016-11-09 | インセプタム リサーチ アンド セラピューティクス,インク. | 精神神経性の疾病を処置するためのプロスタグランジンを含む組成物 |
-
2012
- 2012-08-03 CN CN201280049026.4A patent/CN103841966A/zh active Pending
- 2012-08-03 EP EP12822053.0A patent/EP2739278A4/en not_active Withdrawn
- 2012-08-03 MX MX2014001409A patent/MX359697B/es active IP Right Grant
- 2012-08-03 NZ NZ620300A patent/NZ620300A/en not_active IP Right Cessation
- 2012-08-03 KR KR1020147005555A patent/KR20140076551A/ko not_active Ceased
- 2012-08-03 WO PCT/JP2012/070411 patent/WO2013022079A1/en active Application Filing
- 2012-08-03 SG SG10201606442QA patent/SG10201606442QA/en unknown
- 2012-08-03 CA CA2842455A patent/CA2842455A1/en not_active Abandoned
- 2012-08-03 BR BR112014002712A patent/BR112014002712A8/pt not_active Application Discontinuation
- 2012-08-03 RU RU2014108423A patent/RU2648474C2/ru not_active IP Right Cessation
- 2012-08-03 CN CN201711097031.3A patent/CN107903173A/zh active Pending
- 2012-08-03 TW TW101127939A patent/TWI619497B/zh not_active IP Right Cessation
- 2012-08-03 TW TW106134526A patent/TWI619498B/zh not_active IP Right Cessation
- 2012-08-03 US US13/566,353 patent/US8592483B2/en not_active Expired - Fee Related
- 2012-08-03 AU AU2012293157A patent/AU2012293157A1/en not_active Abandoned
- 2012-08-03 JP JP2014523545A patent/JP6193230B2/ja not_active Expired - Fee Related
- 2012-08-06 AR ARP120102867A patent/AR087468A1/es unknown
-
2013
- 2013-09-26 US US14/038,539 patent/US20140031428A1/en not_active Abandoned
-
2014
- 2014-01-20 IL IL230552A patent/IL230552A/en active IP Right Grant
- 2014-01-29 ZA ZA2014/00707A patent/ZA201400707B/en unknown
-
2017
- 2017-05-10 AU AU2017203092A patent/AU2017203092B2/en not_active Ceased
- 2017-08-09 JP JP2017154092A patent/JP2017222708A/ja active Pending
- 2017-09-03 IL IL254289A patent/IL254289A0/en unknown
-
2018
- 2018-09-11 HK HK18111638.5A patent/HK1252353A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP2739278A1 (en) | 2014-06-11 |
MX2014001409A (es) | 2014-05-28 |
RU2014108423A (ru) | 2015-09-10 |
TWI619497B (zh) | 2018-04-01 |
TW201808302A (zh) | 2018-03-16 |
IL230552A (en) | 2017-09-28 |
WO2013022079A1 (en) | 2013-02-14 |
JP2017222708A (ja) | 2017-12-21 |
TWI619498B (zh) | 2018-04-01 |
AU2017203092A1 (en) | 2017-06-01 |
NZ620300A (en) | 2015-09-25 |
AU2012293157A1 (en) | 2014-03-13 |
US20140031428A1 (en) | 2014-01-30 |
US20130035393A1 (en) | 2013-02-07 |
AR087468A1 (es) | 2014-03-26 |
US8592483B2 (en) | 2013-11-26 |
RU2648474C2 (ru) | 2018-03-26 |
CN103841966A (zh) | 2014-06-04 |
JP6193230B2 (ja) | 2017-09-06 |
IL230552A0 (en) | 2014-03-31 |
JP2014527048A (ja) | 2014-10-09 |
CA2842455A1 (en) | 2013-02-14 |
TW201316992A (zh) | 2013-05-01 |
KR20140076551A (ko) | 2014-06-20 |
BR112014002712A2 (pt) | 2017-06-13 |
MX359697B (es) | 2018-10-08 |
BR112014002712A8 (pt) | 2017-06-20 |
ZA201400707B (en) | 2014-11-26 |
AU2017203092B2 (en) | 2018-11-08 |
IL254289A0 (en) | 2017-10-31 |
EP2739278A4 (en) | 2015-03-18 |
HK1252353A1 (zh) | 2019-05-24 |
CN107903173A (zh) | 2018-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201400005B (en) | Method for treating eczema | |
PL2685961T3 (pl) | Sposób leczenia urazu neurologicznego | |
EP2698464A4 (en) | WASHING METHOD | |
IL231515A0 (en) | Methods for treating hepatitis C virus | |
EP2760359A4 (en) | METHOD FOR TREATING EYE STATES | |
EP2753275A4 (en) | METHODS OF TREATING OCULAR CONDITIONS | |
IL231495A0 (en) | A method for treating osteoporosis | |
ZA201208219B (en) | Method for treating wasterwater | |
GB201118838D0 (en) | Process for treating an underground formation | |
ZA201400544B (en) | Method for treating industrial waste | |
PL2729233T3 (pl) | Sposób kontrolowania mgły | |
PL2691219T3 (pl) | Sposób obróbki tekstyliów technicznych | |
EP2743258A4 (en) | PROCESS FOR PURIFYING LEVO-OXIRACETAM | |
RS60835B1 (sr) | Metoda za lečenje osteoporoze | |
ME01533B (me) | Postupak za obradu prerađene kože | |
EP2694077A4 (en) | METHOD FOR TREATING ASTHENOPY | |
EP2723348A4 (en) | METHOD FOR THE TREATMENT OF ADIPOSITAS | |
IL228744A0 (en) | A method for treating diseases related to interferon alpha | |
EP2691104A4 (en) | USE OF EZATIOSTAT IN THE TREATMENT OF MULTIPLE MYELOMA | |
ZA201400707B (en) | Method for treating schizophrenia | |
GB201105523D0 (en) | Treatment method | |
HK1196279A (en) | Method for treating schizophrenia | |
AU2011905367A0 (en) | Method for treating liquid |